Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: The use of cell line TE671 as a source of AChR antigen
- 30 April 1994
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 51 (1) , 63-68
- https://doi.org/10.1016/0165-5728(94)90129-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical implementation of anti-acetylcholine receptor antibodies.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population SurveyArchives of Neurology, 1991
- Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic seraJournal of Autoimmunity, 1989
- Anti‐acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cellsNeurology, 1989
- A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671Journal of Neuroscience, 1989
- Misidentified cellNature, 1989
- Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell lineJournal of Neuroimmunology, 1988
- Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat musclePublished by Elsevier ,1988
- Using Monoclonal Antibodies to Determine the Structures of Acetylcholine Receptors from Electric Organs, Muscles, and NeuronsaAnnals of the New York Academy of Sciences, 1987
- Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.Journal of Neurology, Neurosurgery & Psychiatry, 1985